CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,689 | -5.5% | 55,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,788 | +30.8% | 55,000 | +25.0% | 0.00% | +33.3% |
| Q1 2023 | $1,367 | -45.6% | 44,000 | -21.6% | 0.00% | -57.1% |
| Q4 2022 | $2,515 | -99.9% | 56,100 | 0.0% | 0.01% | -12.5% |
| Q3 2022 | $2,724,000 | +16.2% | 56,100 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $2,345,000 | +14.4% | 56,100 | 0.0% | 0.01% | +40.0% |
| Q1 2022 | $2,049,000 | -12.8% | 56,100 | +10.0% | 0.01% | -16.7% |
| Q4 2021 | $2,349,000 | +41.9% | 51,000 | +2.8% | 0.01% | +20.0% |
| Q3 2021 | $1,655,000 | +222.6% | 49,600 | +101.6% | 0.01% | +400.0% |
| Q2 2021 | $513,000 | -5.7% | 24,600 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $544,000 | +7.7% | 24,600 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $505,000 | -71.5% | 24,600 | -69.6% | 0.00% | -75.0% |
| Q3 2020 | $1,772,000 | – | 80,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |